What does a duodenal biopsy showing blunted villous mucosa, increased intra‑epithelial lymphocytes, dense lymphoplasmacytic infiltrate, and a positive immunoglobulin A (IgA) serology indicate?

Celiac Disease Diagnosis Confirmed

This combination of duodenal biopsy findings (blunted villi, increased intraepithelial lymphocytes, dense lymphoplasmacytic infiltrate) plus positive IgA serology establishes the diagnosis of celiac disease. The patient should immediately begin a strict gluten-free diet and receive appropriate nutritional counseling and follow-up 1.

Interpretation of the Biopsy and Serology

The histopathologic findings described are characteristic of celiac disease:

• Blunted and flattened villous mucosa = villous atrophy (the hallmark of celiac disease)
• Increased intraepithelial lymphocytes (IELs) = immune response to gluten
• Dense lymphoplasmacytic infiltrate in lamina propria = chronic inflammatory response

When combined with positive IgA serology (presumably anti-tissue transglutaminase IgA or anti-endomysial antibodies), this clinches the diagnosis of celiac disease 1, 2. The pathologist appropriately listed celiac disease first in the differential diagnosis because it is by far the most likely diagnosis given positive serology.

Why This Is Celiac Disease and Not the Other Differentials

The pathologist mentioned three possibilities, but the positive IgA serology essentially rules out the alternatives:

• Whipple's disease: Would show PAS-positive macrophages with Tropheryma whipplei organisms on special stains; not associated with positive celiac serology
• Giardia: Would show trophozoites on the mucosal surface; parasitic infection doesn't cause positive celiac antibodies
• Celiac disease: The only condition that combines these histologic findings with positive IgA antibodies

Recent evidence confirms that villous atrophy, mucosal flattening, and increased IELs are strongly associated with celiac disease (p ≤ 0.001), and positive anti-TG2 and EMA correlate directly with the degree of mucosal damage 2.

Immediate Management Steps

Do not delay initiating a gluten-free diet now that both histology and serology confirm the diagnosis 1. Key actions include:

1. Start strict gluten-free diet immediately to prevent complications (malabsorption, anemia, osteoporosis, increased mortality risk)
2. Refer to dietitian experienced in celiac disease for comprehensive dietary education
3. Screen for nutritional deficiencies: iron, folate, vitamin B12, vitamin D, calcium
4. Baseline bone density assessment if adult (osteoporosis risk)
5. Screen first-degree relatives (10% risk of celiac disease)

Follow-Up Strategy

The 2019 AGA guideline emphasizes that adherence to follow-up is critical but often poor (only 35% of adults maintain follow-up at 4 years), and 20% of adults develop therapy-resistant disease 1. Therefore:

• Schedule regular follow-up visits (3-6 months initially, then annually)
• Monitor serologic response: IgA antibodies should decline and normalize on gluten-free diet
• Assess dietary adherence at each visit
• Repeat biopsy is generally not needed if symptoms resolve and antibodies normalize, though this remains somewhat controversial 1

Important Caveats

While increased IELs can occur in other conditions (autoimmune disorders, NSAIDs, bacterial overgrowth), these typically show normal villous architecture, not the blunted/flattened villi seen here 3, 4. The combination of villous atrophy plus positive serology makes celiac disease the definitive diagnosis.

The patient must understand: Even asymptomatic gluten exposure causes ongoing intestinal damage and increases risk of complications including lymphoma, so strict lifelong adherence to gluten-free diet is non-negotiable 1.